RecruitingNCT06669520

Correlation of Blood Serum Renalase and Microcirculation Obstruction in Patients with Acute Myocardial Infarction After Primary Percutaneous Coronary Intervention


Sponsor

The Third Xiangya Hospital of Central South University

Enrollment

200 participants

Start Date

Aug 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This research will explore the association between blood serum renalase and microcirculation obstruction in patients with acute myocardial infarction (AMI) after primary percutaneous coronary intervention (PCI). The investigators aim to identify potential risk factors for microcirculation obstruction in AMI patients after PPCI.


Eligibility

Min Age: 18 Years

Inclusion Criteria6

  • Age ≥ 18 years;
  • STEMI symptom onset time < 12 hours;
  • STEMI symptom onset time 12-48 hours with persistent ischemic symptoms, hemodynamic instability, or life-threatening ventricular arrhythmias;
  • High-risk NSTEMI;
  • Emergency PCI;
  • Voluntary informed consent.

Exclusion Criteria5

  • Non-obstructive acute myocardial infarction;
  • Severe chronic kidney disease (defined as estimated glomerular filtration rate < 20 mL/min per 1.73 m²);
  • Life expectancy < 1 year;
  • Pregnant or planning to become pregnant;
  • Emergency PCI failure.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

The Third Xiangya Hospital of Central South University

Changsha, Hunan, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06669520


Related Trials